Evaluating Depression Among Acne Vulgaris Patients Treated With Isotretinoin

被引:4
|
作者
Algamdi, Bader N. [1 ]
ALdahlan, Hussam W. [1 ]
ALALhareth, Hussain [1 ]
Alghamdi, Radhwan [1 ]
Alkhouzaie, Moath T. [2 ]
ALahmari, Nawaf [1 ]
Alhudaifi, Abdulrahman [1 ]
Alkasih, Yaser [1 ]
Elyahia, Wyle [1 ]
ALghamdi, Khalid [1 ]
机构
[1] King Fahd Hosp Univ, Dermatol, Khobar, Saudi Arabia
[2] King Fahad Univ Hosp, Vasc Surg, Khobar, Saudi Arabia
关键词
acne vulgaris; isotretinoin; depression; MOOD; RISK;
D O I
10.7759/cureus.12126
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Isotretinoin is the most effective treatment for moderate to severe acne. However, isotretinoin has many side effects related to its use. Since 1983, when Hetzen reported the first occurrence of new depressive symptoms in patients treated with isotretinoin, a lot of controversies emerged regarding the causal relationship between isotretinoin and depression. Objective To evaluate depression among acne patients treated with isotretinoin versus doxycycline at King Fahad Hospital of the University between December 2019-March 2020. Methods Using the Global Acne Grading System, patients aged 18 - 30 years old with moderate to severe acne vulgaris who have not received isotretinoin previously and has no personal or family history of any psychiatric illnesses, were evaluated for depression using the patient health questionnaire-9 before starting treatment and 8 weeks after. Twenty-nine patients had met the inclusion criteria and were included in the study. Results Of the 29 patients included, 18 patients completed the study (nine males, nine females). Twelve patients received isotretinoin 0.5mg/kg (study group) and six patients received doxycycline 100mg (control group). The mean depression score for the isotretinoin group has decreased from (4 +/- 2.48) to (3.08 * 2.84) but the result was statistically insignificant with a p-value of 0.19, CI (-5.28, 2.36). For the doxycycline group, the mean depression score has decreased from (5.5 +/- 2.5) to (2.83 +/- 0.75) with a p-value of 0.043, CI (0.12, 5.21). There was no statistically significant difference in the mean depression score between the two groups after 8 weeks of starting treatment [p-valve 0.837, CI (-2.28, 2.78)]. Conclusion This study showed that, after 8 weeks of starting treatment, isotretinoin at 0.5 mg/kg has no risk of developing depression. The results of this study did not reveal a direct relationship between the use of isotretinoin and the development of depression. Furthermore, optimum control and treatment of acne vulgaris have shown to improve depression scores.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Evaluation of Side Effects of Isotretinoin in 150 Patients with Acne Vulgaris
    Karadag, Ayse Serap
    Calka, Omer
    Akdeniz, Necmettin
    [J]. TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2011, 45 (01): : 37 - 42
  • [32] Isotretinoin is key in treating acne vulgaris
    Fenton, Caroline
    Kang, Connie
    [J]. DRUGS & THERAPY PERSPECTIVES, 2021, 37 (04) : 150 - 156
  • [33] The frequency of hematuria in acne vulgaris patients during isotretinoin treatment
    Yesilkaya, Burcu
    Alli, Nuran
    Artuz, R. Ferda
    Ulu, Ezgi
    Kartal, Demet
    Cinar, S. Levent
    [J]. CUTANEOUS AND OCULAR TOXICOLOGY, 2017, 36 (01) : 74 - 76
  • [34] Treatment outcome of acne vulgaris with oral isotretinoin in 89 patients
    Ng, PPL
    Goh, CL
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 1999, 38 (03) : 213 - 216
  • [35] Effect of oral isotretinoin on anxiety and depression in patients with acne
    Nikam, Balkrisha
    Jamale, Varsha
    Ravikumar, S. Tapdia
    [J]. JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2020, 11 (03) : 113 - 118
  • [36] Does isotretinoin cause depression and anxiety in acne patients?
    Metekoglu, Safak
    Oral, Esat
    Ucar, Cagla
    Akalin, Mehmet
    [J]. DERMATOLOGIC THERAPY, 2019, 32 (02)
  • [37] Utility of studying the ocular surface in patients with acne vulgaris treated with oral isotretinoin:: a randomized controlled trial
    Aragona, P
    Cannavò, SP
    Borgia, F
    Guarneri, F
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (03) : 576 - 578
  • [38] No evidence for increased anxiety in acne patients treated with isotretinoin
    Huang, Y. -C.
    Cheng, Y. -C.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (07) : E344 - E345
  • [39] Depression and suicide in patients treated with isotretinoin
    Wysowski, DK
    Pitts, M
    Beitz, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (06): : 460 - 460
  • [40] Acne fulminans: exacerbation of acne vulgaris during isotretinoin treatment?
    Bialek, Kamila
    Alekseenko, Ana
    Wojas-Pelc, Anna
    [J]. PRZEGLAD DERMATOLOGICZNY, 2011, 98 (06): : 496 - 500